Moreover, the performance of PIVKA-II in discriminating AFP-negative HCC from benign liver diseases was still noticeable (AUCPIVKA-II = 0.76, P < 0.01) with a sensitivity of 74.19% and specificity of 82.68%. Here, AFP is linked to hepatocellular carcinoma.